drugset / Trial / NCT01455220

The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis

NCT01455220

Completed 45 enrolled University of South Florida
NaSingle-groupOpen-labelSupportive care

Summary

The purpose of this study is to determine if sexual dysfunction symptoms and quality of life measures in patients with Multiple Sclerosis may be improved in patients that are prescribed Tysabri.

Timeline

Start
2011-01
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject natalizumab Monoclonal antibody Intravenous

Indications